Public health activists estimate Roche earned significantly more from risdiplam, a spinal muscular atrophy drug, than its ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

In which young patients with spinal muscular atrophy will spinal braces and growing rods be most helpful? Ashley Webb, MD, assistant professor of pediatric neurology and neuromuscular program ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for ...

Biotech stock Scholar Rock (NASDAQ: SRRK) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds. Scholar Rock targets relatively uncommon disorders ...

Multidisciplinary coordination across prescribing teams, nursing, laboratory medicine, finance, and infusion centers is ...

Jokes by comedian Samay Raina - that allegedly mock blind people and an infant suffering from spinal muscular atrophy, and requiring a Rs 16 lakh injection to survive - have been flagged by the ...

For a boy with SMA in China, starting Evrysdi (risdiplam) just 12 days after birth was safe and helped him reach key motor ...